-
The Cochrane PaPaS Group closes on 31 March 2023 due to a loss of funding and this website will be archived; please contact support@cochrane.org with any questions. For further information, please visit https://papas.cochrane.org/news/important-funding-update.
February 28 2023
-
We regularly send out newsletters to keep everyone updated on what Cochrane PaPaS has been doing recently. Please sign up to our newsletter here.Please click here to view our latest newsletter. See below for previous newsletters.Previous newslettersOctober 2022June 2022March 2022December 2021October 2021August 2021June 2021April 2021...
December 19 2022
-
Our ten most accessed reviews in 2021 (reviews published anytime) are shown below.Congratulations to everyone involved.1. Needle size for vaccination procedures in children and adolescents (DOI: 10.1002/14651858.CD010720.pub3). See full review here. 2. Cannabis-based medicines for...
November 24 2022
-
Our top ten most cited reviews contributing to the 2021 Impact Factor (i.e. those published in 2019 and 2020, and cited in 2021) are shown below.Congratulations to everyone involved.1. Pregabalin for neuropathic pain in adults (DOI: 10.1002/14651858.CD007076.pub3). See full review here. 2. ...
November 24 2022
-
Cochrane PaPaS: Trust, Integrity and the Future of Pain EvidenceRegistration for this event is closing soon. Register below or see our dedicated webpage for further information. RegistrationTo register for this event in London you will need to book your free Ticket through Eventbrite, here: Pain, Integrity and the Future of Pain Evidence...
November 15 2022
-
***The Cochrane PaPaS Group closes on 31 March 2023 and this website will be archived; please contact support@cochrane.org with any questions***About our eventPain in clinical practice and patient care is often poorly served by an evidence architecture containing multiple structural weaknesses. These issues span across pre-clinical research,...
August 5 2022
-
The podcast for the review Prophylactic antiemetics for adults receiving intravenous opioids in the acute care setting is now published. Hear from lead author, Michael Gottlieb, from the Department of Emergency Medicine at Rush University Medical Center in Chicago, USA, here. Read the full review on the Cochrane Library here.
August 3 2022
-
We will be hosting an event on "Trust and integrity in pain evidence and practice" to be held on Wednesday 7th December 2022, at a venue in London, more details to follow in the coming months.
July 5 2022
-
We have received the latest data on Pain, Palliative and Supportive Care Review Group Cochrane Reviews used to inform clinical guidelines published between 1 January 2020 to 31 March 2022.Total of 219 individual PaPaS Reviews have informed 140 guidelines.Summary of NICE & SIGN Guideline data105 reviews in: 6 NICE guidelines; 1...
June 16 2022
-
Did you know that at PaPaS we have been defining and delivering high quality evidence synthesis in pain, palliative and supportive care for 23 years? Check out this summary of what we are all about!
March 21 2022
The Cochrane PaPaS Group closes on 31 March 2023 due to a loss of funding and this website will be archived; please contact support@cochrane.org with any questions. For further information, please visit https://papas.cochrane.org/news/important-funding-update.February 28 2023
We regularly send out newsletters to keep everyone updated on what Cochrane PaPaS has been doing recently. Please sign up to our newsletter here.Please click here to view our latest newsletter. See below for previous newsletters.Previous newslettersOctober 2022June 2022March 2022December 2021October 2021August 2021June 2021April 2021...December 19 2022
Our ten most accessed reviews in 2021 (reviews published anytime) are shown below.Congratulations to everyone involved.1. Needle size for vaccination procedures in children and adolescents (DOI: 10.1002/14651858.CD010720.pub3). See full review here. 2. Cannabis-based medicines for...November 24 2022
Our top ten most cited reviews contributing to the 2021 Impact Factor (i.e. those published in 2019 and 2020, and cited in 2021) are shown below.Congratulations to everyone involved.1. Pregabalin for neuropathic pain in adults (DOI: 10.1002/14651858.CD007076.pub3). See full review here. 2. ...November 24 2022
Cochrane PaPaS: Trust, Integrity and the Future of Pain EvidenceRegistration for this event is closing soon. Register below or see our dedicated webpage for further information. RegistrationTo register for this event in London you will need to book your free Ticket through Eventbrite, here: Pain, Integrity and the Future of Pain Evidence...November 15 2022
***The Cochrane PaPaS Group closes on 31 March 2023 and this website will be archived; please contact support@cochrane.org with any questions***About our eventPain in clinical practice and patient care is often poorly served by an evidence architecture containing multiple structural weaknesses. These issues span across pre-clinical research,...August 5 2022
The podcast for the review Prophylactic antiemetics for adults receiving intravenous opioids in the acute care setting is now published. Hear from lead author, Michael Gottlieb, from the Department of Emergency Medicine at Rush University Medical Center in Chicago, USA, here. Read the full review on the Cochrane Library here.August 3 2022
We will be hosting an event on "Trust and integrity in pain evidence and practice" to be held on Wednesday 7th December 2022, at a venue in London, more details to follow in the coming months.July 5 2022
We have received the latest data on Pain, Palliative and Supportive Care Review Group Cochrane Reviews used to inform clinical guidelines published between 1 January 2020 to 31 March 2022.Total of 219 individual PaPaS Reviews have informed 140 guidelines.Summary of NICE & SIGN Guideline data105 reviews in: 6 NICE guidelines; 1...June 16 2022
Did you know that at PaPaS we have been defining and delivering high quality evidence synthesis in pain, palliative and supportive care for 23 years? Check out this summary of what we are all about!March 21 2022